×
Entrez Id:
3077
Gene Symbol:
HFE
HFE
0.090
GeneticVariation
disease
BEFREE
Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis .
10488699
1999
×
Entrez Id:
3077
Gene Symbol:
HFE
HFE
0.090
GeneticVariation
disease
BEFREE
Nonalcoholic steatohepatitis in Asian Indians is neither associated with iron overload nor with HFE gene mutations.
15637751
2005
×
Entrez Id:
7040
Gene Symbol:
TGFB1
TGFB1
0.340
AlteredExpression
disease
BEFREE
Nonalcoholic steatohepatitis (NASH), when compared with simple steatosis (SS), significantly increases the expression of TGFB1 (6.8, p<0.005), angiotensin I-converting enzyme (ACE) (2.1, p<0.007), LAMA1 (2.1, p<0.007), SERPINB2 (2.1, p<0.007), CSF2 (2.5, p<0.002), IL1A (2.5, p<0.005), IL3 (2.1, p<0.007), IL4 (2.1, p<0.007), LIF (2.1, p<0.007), and MMP1 (2.1, p<0.007), and decreases the transcript levels of genes involved in the negative regulation of cell-death pathways.
21664615
2011
×
Entrez Id:
1636
Gene Symbol:
ACE
ACE
0.310
AlteredExpression
disease
BEFREE
Nonalcoholic steatohepatitis (NASH), when compared with simple steatosis (SS), significantly increases the expression of TGFB1 (6.8, p<0.005), angiotensin I-converting enzyme (ACE) (2.1, p<0.007), LAMA1 (2.1, p<0.007), SERPINB2 (2.1, p<0.007), CSF2 (2.5, p<0.002), IL1A (2.5, p<0.005), IL3 (2.1, p<0.007), IL4 (2.1, p<0.007), LIF (2.1, p<0.007), and MMP1 (2.1, p<0.007), and decreases the transcript levels of genes involved in the negative regulation of cell-death pathways.
21664615
2011
×
Entrez Id:
284217
Gene Symbol:
LAMA1
LAMA1
0.310
AlteredExpression
disease
BEFREE
Nonalcoholic steatohepatitis (NASH), when compared with simple steatosis (SS), significantly increases the expression of TGFB1 (6.8, p<0.005), angiotensin I-converting enzyme (ACE) (2.1, p<0.007), LAMA1 (2.1, p<0.007), SERPINB2 (2.1, p<0.007), CSF2 (2.5, p<0.002), IL1A (2.5, p<0.005), IL3 (2.1, p<0.007), IL4 (2.1, p<0.007), LIF (2.1, p<0.007), and MMP1 (2.1, p<0.007), and decreases the transcript levels of genes involved in the negative regulation of cell-death pathways.
21664615
2011
SERPINB2
0.310
AlteredExpression
disease
BEFREE
Nonalcoholic steatohepatitis (NASH), when compared with simple steatosis (SS), significantly increases the expression of TGFB1 (6.8, p<0.005), angiotensin I-converting enzyme (ACE) (2.1, p<0.007), LAMA1 (2.1, p<0.007), SERPINB2 (2.1, p<0.007), CSF2 (2.5, p<0.002), IL1A (2.5, p<0.005), IL3 (2.1, p<0.007), IL4 (2.1, p<0.007), LIF (2.1, p<0.007), and MMP1 (2.1, p<0.007), and decreases the transcript levels of genes involved in the negative regulation of cell-death pathways.
21664615
2011
×
Entrez Id:
1437
Gene Symbol:
CSF2
CSF2
0.310
AlteredExpression
disease
BEFREE
Nonalcoholic steatohepatitis (NASH), when compared with simple steatosis (SS), significantly increases the expression of TGFB1 (6.8, p<0.005), angiotensin I-converting enzyme (ACE) (2.1, p<0.007), LAMA1 (2.1, p<0.007), SERPINB2 (2.1, p<0.007), CSF2 (2.5, p<0.002), IL1A (2.5, p<0.005), IL3 (2.1, p<0.007), IL4 (2.1, p<0.007), LIF (2.1, p<0.007), and MMP1 (2.1, p<0.007), and decreases the transcript levels of genes involved in the negative regulation of cell-death pathways.
21664615
2011
×
Entrez Id:
3552
Gene Symbol:
IL1A
IL1A
0.310
AlteredExpression
disease
BEFREE
Nonalcoholic steatohepatitis (NASH), when compared with simple steatosis (SS), significantly increases the expression of TGFB1 (6.8, p<0.005), angiotensin I-converting enzyme (ACE) (2.1, p<0.007), LAMA1 (2.1, p<0.007), SERPINB2 (2.1, p<0.007), CSF2 (2.5, p<0.002), IL1A (2.5, p<0.005), IL3 (2.1, p<0.007), IL4 (2.1, p<0.007), LIF (2.1, p<0.007), and MMP1 (2.1, p<0.007), and decreases the transcript levels of genes involved in the negative regulation of cell-death pathways.
21664615
2011
×
Entrez Id:
3976
Gene Symbol:
LIF
LIF
0.310
AlteredExpression
disease
BEFREE
Nonalcoholic steatohepatitis (NASH), when compared with simple steatosis (SS), significantly increases the expression of TGFB1 (6.8, p<0.005), angiotensin I-converting enzyme (ACE) (2.1, p<0.007), LAMA1 (2.1, p<0.007), SERPINB2 (2.1, p<0.007), CSF2 (2.5, p<0.002), IL1A (2.5, p<0.005), IL3 (2.1, p<0.007), IL4 (2.1, p<0.007), LIF (2.1, p<0.007), and MMP1 (2.1, p<0.007), and decreases the transcript levels of genes involved in the negative regulation of cell-death pathways.
21664615
2011
×
Entrez Id:
4312
Gene Symbol:
MMP1
MMP1
0.310
AlteredExpression
disease
BEFREE
Nonalcoholic steatohepatitis (NASH), when compared with simple steatosis (SS), significantly increases the expression of TGFB1 (6.8, p<0.005), angiotensin I-converting enzyme (ACE) (2.1, p<0.007), LAMA1 (2.1, p<0.007), SERPINB2 (2.1, p<0.007), CSF2 (2.5, p<0.002), IL1A (2.5, p<0.005), IL3 (2.1, p<0.007), IL4 (2.1, p<0.007), LIF (2.1, p<0.007), and MMP1 (2.1, p<0.007), and decreases the transcript levels of genes involved in the negative regulation of cell-death pathways.
21664615
2011
×
Entrez Id:
3565
Gene Symbol:
IL4
IL4
0.310
AlteredExpression
disease
BEFREE
Nonalcoholic steatohepatitis (NASH), when compared with simple steatosis (SS), significantly increases the expression of TGFB1 (6.8, p<0.005), angiotensin I-converting enzyme (ACE) (2.1, p<0.007), LAMA1 (2.1, p<0.007), SERPINB2 (2.1, p<0.007), CSF2 (2.5, p<0.002), IL1A (2.5, p<0.005), IL3 (2.1, p<0.007), IL4 (2.1, p<0.007), LIF (2.1, p<0.007), and MMP1 (2.1, p<0.007), and decreases the transcript levels of genes involved in the negative regulation of cell-death pathways.
21664615
2011
×
Entrez Id:
3562
Gene Symbol:
IL3
IL3
0.310
AlteredExpression
disease
BEFREE
Nonalcoholic steatohepatitis (NASH), when compared with simple steatosis (SS), significantly increases the expression of TGFB1 (6.8, p<0.005), angiotensin I-converting enzyme (ACE) (2.1, p<0.007), LAMA1 (2.1, p<0.007), SERPINB2 (2.1, p<0.007), CSF2 (2.5, p<0.002), IL1A (2.5, p<0.005), IL3 (2.1, p<0.007), IL4 (2.1, p<0.007), LIF (2.1, p<0.007), and MMP1 (2.1, p<0.007), and decreases the transcript levels of genes involved in the negative regulation of cell-death pathways.
21664615
2011
×
Entrez Id:
338
Gene Symbol:
APOB
APOB
0.020
GeneticVariation
disease
BEFREE
Non-alcoholic steatohepatitis -related cirrhosis in a patient with APOB L343V familial hypobetalipoproteinaemia.
23694813
2013
×
Entrez Id:
6579
Gene Symbol:
SLCO1A2
SLCO1A2
0.010
AlteredExpression
disease
BEFREE
Non-alcoholic steatohepatitis (NASH) in humans and in a diet-induced rodent model alter the expression of multiple OATP transporters.
24613363
2014
×
Entrez Id:
367
Gene Symbol:
AR
AR
0.020
Biomarker
disease
BEFREE
Nonalcoholic steatohepatitis -related hepatocellular carcinoma: is there a role for the androgen receptor pathway?
28424556
2017
×
Entrez Id:
8837
Gene Symbol:
CFLAR
CFLAR
0.030
Biomarker
disease
BEFREE
Non-alcoholic steatohepatitis (NASH) is a chronic metabolic syndrome and the CFLAR -JNK pathway can reverse the process of NASH.
31384535
2019
×
Entrez Id:
5599
Gene Symbol:
MAPK8
MAPK8
0.040
Biomarker
disease
BEFREE
Non-alcoholic steatohepatitis (NASH) is a chronic metabolic syndrome and the CFLAR-JNK pathway can reverse the process of NASH.
31384535
2019
×
Entrez Id:
9370
Gene Symbol:
ADIPOQ
ADIPOQ
0.380
Biomarker
disease
BEFREE
Adiponectin and its receptors in non-alcoholic steatohepatitis .
15591515
2005
×
Entrez Id:
5465
Gene Symbol:
PPARA
PPARA
0.390
GeneticVariation
disease
BEFREE
Peroxisome proliferator-activated receptor alpha L162V polymorphism in nonalcoholic steatohepatitis and genotype 1 hepatitis C virus-related liver steatosis.
16297361
2005
×
Entrez Id:
1118
Gene Symbol:
CHIT1
CHIT1
0.010
AlteredExpression
disease
BEFREE
CHIT expression differed markedly in livers from normal controls and in those from patients with simple steatosis or non-alcoholic steatohepatitis .
16825325
2006
×
Entrez Id:
7124
Gene Symbol:
TNF
TNF
0.100
Biomarker
disease
BEFREE
Tumor necrosis factor (TNF ) is considered to play a role in the second hit of non-alcoholic steatohepatitis (NASH).
17395331
2007
×
Entrez Id:
4524
Gene Symbol:
MTHFR
MTHFR
0.010
GeneticVariation
disease
BEFREE
Methylenetetrahydrofolate reductase gene polymorphisms in patients with nonalcoholic steatohepatitis (NASH).
17563923
2008
×
Entrez Id:
3077
Gene Symbol:
HFE
HFE
0.090
GeneticVariation
disease
BEFREE
HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis .
17680648
2007
×
Entrez Id:
3929
Gene Symbol:
LBP
LBP
0.020
AlteredExpression
disease
BEFREE
Lipopolysaccharide-binding protein plasma levels and liver TNF-alpha gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of non-alcoholic steatohepatitis .
18000721
2007
×
Entrez Id:
5728
Gene Symbol:
PTEN
PTEN
0.310
Biomarker
disease
BEFREE
PTEN in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and cancer.
20460918
2010